Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Pathology

• Publication date

  1999-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jcp.52.5.363PMID 10560357PMCID PMC1023073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma.

  1998cited by this paper
• K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.

  1997cited by this paper
• Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors.

  1997cited by this paper
• Microsatellite instability of D17S513 on chromosome 17 is associated with progression of breast cancer.

  1997cited by this paper
• Microsatellite alterations in serum DNA of head and neck cancer patients

  1996cited by this paper
• Cancer and mutant DNA in blood plasma.

  1996cited by this paper
• Microsatellite alterations in plasma DNA of small cell lung cancer patients

  1996cited by this paper
• Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer.

  1996cited by this paper
• Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

  1996cited by this paper
• An efficient method for the extraction of DNA from vertebrate tissues.

  1996cited by this paper
• Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.

  1995cited by this paper
• Microsatellite instability and loss of heterozygosity in breast cancer.

  1994cited by this paper
• Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia

  1994cited by this paper
• Microsatellite alterations as clonal markers for the detection of human cancer.

  1994cited by this paper
• Neoplastic characteristics of the DNA found in the plasma of cancer patients.

  1989cited by this paper
• Isolation and characterization of DNA from the plasma of cancer patients.

  1987cited by this paper
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper

• Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions

  2017cites this paper
• Circulating Nucleic Acids (RNA/DNA) in Breast Cancer

  2016cites this paper
• Effect of zinc and polyphenols supplementation on antioxidative defense mechanisms and the frequency of microsatellite instability in chemically-induced mammary carcinogenesis in the rat

  2015cites this paper
• Epigenetic Study of Plasma Circulating DNA in Prostate Cancer

  2015cites this paper
• Cell-free DNA in the circulation as a potential cancer biomarker.

  2011cites this paper
• Breast cancer circulating tumor cells

  2011cites this paper
• Analysis of methylated circulating DNA in cancer patients' blood.

  2009cites this paper
• Circulating nucleic acids (CNAs) and cancer--a survey.

  2007cites this paper
• Differential prioritization between relevance and redundancy in correlation-based feature selection techniques for multiclass gene expression data

  2006cites this paper
• Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.

  2006cites this paper
• Diagnostische Bedeutung zirkulierender DNA- Fragmente in der Onkologie. Diagnostic importance of circulating DNA fragments in oncology

  2005cites this paper
• The detection of circulating breast cancer cells in blood

  2004cites this paper
• Microsatellite Alterations as Diagnostic and Prognostic Molecular Markers in Patients With Cancer

  2004cites this paper
• Microsatellite instability: theory and methods.

  2004cites this paper
• Nukleosomen als Zelltodparameter bei Patienten mit malignen Tumoren

  2004cites this paper
• Loss of heterozygosity in serial plasma DNA samples during follow‐up of women with breast cancer

  2003cites this paper
• Diagnostic potential of circulating nucleic acids for oncology

  2003cites this paper
• Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.

  2003cites this paper
• Tumor-speci¢c DNA in plasma of breast cancer patients

  2002cites this paper
• Cell-free DNA: measurement in various carcinomas and establishment of normal reference range.

  2002cites this paper
• Persistence of tumor DNA in plasma of breast cancer patients after mastectomy

  2002cites this paper
• Tumor-specific DNA in plasma of breast cancer patients

  2002cites this paper
• p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.

  2002cites this paper
• Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.

  2002cites this paper
• [Secreted tumor markers and breast cancer].

  2002cites this paper
• RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma

  2002cites this paper
• Marcadores tumorales de secreción y cáncer de mama

  2002cites this paper
• Genomic instability in chronic viral hepatitis and hepatocellular carcinoma.

  2001cites this paper
• Microsatellite Alterations Detected in the Serum of Early Stage Breast Cancer Patients

  2001cites this paper
• Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics.

  2001cites this paper
• Nucleosomes in serum of patients with benign and malignant diseases

  2001cites this paper
• Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations

  2001cites this paper
• Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.

  2001cites this paper
• Tumor DNA in plasma of breast cancer patients. Relation to treatment

  2000cites this paper
• Telomerase RNA as a detection marker in the serum of breast cancer patients.

  2000cites this paper